These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 35459617)

  • 21. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.
    Wei R; Yang J; Cheng CW; Ho WI; Li N; Hu Y; Hong X; Fu J; Yang B; Liu Y; Jiang L; Lai WH; Au KW; Tsang WL; Tse YL; Ng KM; Esteban MA; Tse HF
    JHEP Rep; 2022 Jan; 4(1):100389. PubMed ID: 34877514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.
    Thamodaran V; Rani S; Velayudhan SR
    Methods Mol Biol; 2022; 2454():755-773. PubMed ID: 33830454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy.
    Escribá R; Larrañaga-Moreira JM; Richaud-Patin Y; Pourchet L; Lazis I; Jiménez-Delgado S; Morillas-García A; Ortiz-Genga M; Ochoa JP; Carreras D; Pérez GJ; de la Pompa JL; Brugada R; Monserrat L; Barriales-Villa R; Raya A
    Circ Res; 2023 Jul; 133(2):108-119. PubMed ID: 37317833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Song Y; Zheng Z; Lian J
    Front Cardiovasc Med; 2022; 9():889519. PubMed ID: 35647048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies.
    McTague A; Rossignoli G; Ferrini A; Barral S; Kurian MA
    Front Genome Ed; 2021; 3():630600. PubMed ID: 34713254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studying Kidney Disease Using Tissue and Genome Engineering in Human Pluripotent Stem Cells.
    Garreta E; González F; Montserrat N
    Nephron; 2018; 138(1):48-59. PubMed ID: 28988229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome editing of hPSCs: Recent progress in hPSC-based disease modeling for understanding disease mechanisms.
    Choi DK; Kim YK; HoonYu J; Min SH; Park SW
    Prog Mol Biol Transl Sci; 2021; 181():271-287. PubMed ID: 34127196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
    Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
    Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applications of kidney organoids derived from human pluripotent stem cells.
    Kim YK; Nam SA; Yang CW
    Korean J Intern Med; 2018 Jul; 33(4):649-659. PubMed ID: 29961307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes.
    Song M; Yang X; Ren X; Maliskova L; Li B; Jones IR; Wang C; Jacob F; Wu K; Traglia M; Tam TW; Jamieson K; Lu SY; Ming GL; Li Y; Yao J; Weiss LA; Dixon JR; Judge LM; Conklin BR; Song H; Gan L; Shen Y
    Nat Genet; 2019 Aug; 51(8):1252-1262. PubMed ID: 31367015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's in a dish - induced pluripotent stem cell-based disease modeling.
    de Leeuw S; Tackenberg C
    Transl Neurodegener; 2019; 8():21. PubMed ID: 31338163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.
    Zhu Z; González F; Huangfu D
    Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.
    Kizner V; Naujock M; Fischer S; Jäger S; Reich S; Schlotthauer I; Zuckschwerdt K; Geiger T; Hildebrandt T; Lawless N; Macartney T; Dorner-Ciossek C; Gillardon F
    Mol Neurobiol; 2020 Feb; 57(2):616-634. PubMed ID: 31402430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination.
    Martin RM; Ikeda K; Cromer MK; Uchida N; Nishimura T; Romano R; Tong AJ; Lemgart VT; Camarena J; Pavel-Dinu M; Sindhu C; Wiebking V; Vaidyanathan S; Dever DP; Bak RO; Laustsen A; Lesch BJ; Jakobsen MR; Sebastiano V; Nakauchi H; Porteus MH
    Cell Stem Cell; 2019 May; 24(5):821-828.e5. PubMed ID: 31051134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous Cell Type-Specific Disrupted in Schizophrenia 1 Interactomes Reveal Protein Networks Associated With Neurodevelopmental Disorders.
    Wilkinson B; Evgrafov OV; Zheng D; Hartel N; Knowles JA; Graham NA; Ichida JK; Coba MP
    Biol Psychiatry; 2019 Feb; 85(4):305-316. PubMed ID: 29961565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs.
    Guo H; Liu L; Nishiga M; Cong L; Wu JC
    Trends Genet; 2021 Dec; 37(12):1109-1123. PubMed ID: 34509299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.
    Ababneh NA; Scaber J; Flynn R; Douglas A; Barbagallo P; Candalija A; Turner MR; Sims D; Dafinca R; Cowley SA; Talbot K
    Hum Mol Genet; 2020 Aug; 29(13):2200-2217. PubMed ID: 32504093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling the complex genetic architectures of brain disease.
    Fernando MB; Ahfeldt T; Brennand KJ
    Nat Genet; 2020 Apr; 52(4):363-369. PubMed ID: 32203467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.